Login

Healthcare

00:00:00
Abivax seeks partners - Dr. Hartmut Ehrlich, CEO, Abivax
00:00:00
John Burt, chief executive of Abzena PLC
00:00:00
Per Persson, CEO of Acarix
00:00:00
Timothy Morris - CFO, Head of Business Development, AcelRx Pharmaceuticals Inc
00:00:00
Ed Gudaitis, President and CEO, Acerus Pharmaceuticals Corporation
00:00:00
Ed Gudaitis, President and CEO, Acerus Pharmaceuticals Corporation
00:00:00
Ed Gudaitis, President and CEO, Acerus Pharmaceuticals Corporation
00:00:00
AdAlta delivers positive Phase I Extension Study results - Tim Oldham, MD, Adalta Ltd
00:00:00
AdAlta Phase I Extension Study Results - Tim Oldham, MD, Adalta Ltd
00:00:00
Addex Therapeutics CEO Tim Dyer: There is a $4-bil market opportunity in dyskinesia
00:00:00
Admedus Ltd 'in good shape' with minimal disruption to supply chain as it advances SAVR trial - Wayne Paterson, CEO, Admedus Ltd
00:00:00
Admedus Ltd proud to unveil its valves publicly for the first time in London - Wayne Paterson, CEO, Admedus Ltd
00:00:00
Admedus (ASX:AHZ) CEO Wayne Paterson interview
00:00:00
Admedus (ASX:AHZ) CEO Wayne Paterson podcast
00:00:00
Advanced Oncotherapy PLC on its proton beam therapy system - Dr Johnathan Farr , chief clinical officer at Advanced Oncotherapy
00:00:00
Advanced Oncotherapy now has the ammo to "democratise proton therapy", says CEO - Nicolas Serandou, CEO, Advanced Oncotherapy

© 2017 - Neuhu+